Ankaj Khosla MD, Presenter: Nothing to Disclose

Stephen Phillips Reis MD, Abstract Co-Author: Nothing to Disclose

Ali Pirasteh MD, Abstract Co-Author: Nothing to Disclose

Thomas Alfred Pacicco, Abstract Co-Author: Nothing to Disclose

Clayton K. Trimmer DO, Abstract Co-Author: Nothing to Disclose

Sanjeeva P. Kalva MD, Abstract Co-Author: Consultant, CeloNova BioSciences, Inc

In a subset of patients, ablation of pulmonary nodules serves as an alternative to surgical resection of both primary and metastatic lesions in the lung. Following the results of the National Lung Cancer Screening Trial (NLCST), the number of both primary and secondary lung tumors is likely to increase after the implementation of low dose screening CT. In this exhibit we aim to describe the currently available pulmonary ablation technologies. There will be a review of the current literature on lung cancer, staging, pulmonary ablation techniques and a discussion on the indications for ablation. We will go over procedure details with demonstration from our institution and review the variety of probes used in pulmonary radiofrequency ablations. Finally, we will discuss upcoming techniques and their potential.  

1. Background 2. Procedure details and indications 3. Literature review of pulmonary ablation techniques 4. Pictoral review involving a variety of probes 5. New techniques  

http://abstract.rsna.org/uploads/2014/14005192/14005192_4y6d.pdf

Khosla, A, Reis, S, Pirasteh, A, Pacicco, T, Trimmer, C, Kalva, S, Pulmonary Ablation: An Update on Currently Available Ablation Technologies and Their Use in the Lungs.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005192.html